Wolfe Research Assumes argenx SE (ARGX) at Outperform

July 19, 2021 6:48 AM EDT
Get Alerts ARGX Hot Sheet
Price: $456.99 +1.38%

Rating Summary:
    16 Buy, 6 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 12 | Down: 14 | New: 24
Join SI Premium – FREE

Wolfe Research analyst Andrew Galler assumes coverage on argenx SE (NASDAQ: ARGX) with a Outperform rating.

The analyst comments "In this deck, we discuss key investor debates such as efgartigimod's position in the FcRn pecking order, the approvability and launch expectations for efgartigimod in gMG, and expectations for ITP and PV."

For an analyst ratings summary and ratings history on argenx SE click here. For more ratings news on argenx SE click here.

Shares of argenx SE closed at $309.40 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage